Ketek

Ketek (the brand name for Telithromycin) is an antibiotic commonly prescribed for treatment of certain types of pneumonia. Clinical trials were first conducted in France in 1998 and the drug was approved for sale in the United States in 2004.

There has been controversy surrounding the drug since its introduction into world markets, though. One of the medical professionals who participated in the clinical trials went to prison for nearly five years after pleading guilty to falsifying data to cover up concerns that the drug caused serious liver problems. FDA officials challenged the approval of the drug, and the U.S. Congress held hearings, where it was shown that Telithromycin had been tied to a number of serious health events, including four deaths. As a result, the FDA revised the warning labels on the drug, specifically removing two prior approved uses—acute bacterial sinusitis and acute bacterial conditions tied to chronic bronchitis.

If you or someone you love has suffered injury after being prescribed Ketek, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.